Myriad Genetics Stock Plummets on Lower-Than-Expected Q4 Revenues, FDA Interactions on GeneSight Published on Aug 13, 2019  Syapse to Provide Real-World Evidence to FDA Oncology Center of Excellence Published on Aug 14, 2019  Adaptive Biotechnologies' Q2 Revenues Rise 91 Percent Published on Aug 13, 2019  Personalis Q2 Revenues Up 80 Percent Published on Aug 13, 2019  Quanterix Closes $69M Stock Offering Published on Aug 13, 2019  Expedeon Posts 18 Percent Q2 Revenue Increase Published on Aug 14, 2019

Featured in Depth

Complex Genetic Testing Errors Emerge Amid Increasing Panel Use, Consumer Access, Case Series Finds Published on Aug 13, 2019

'Click Chip' CTC Purification Method Enables Identification of Cancer-Linked Genetic Arrangements Published on Aug 12, 2019

Quidel Updates Dx and MDx Commercial Strategies, Pipelines Published on Aug 09, 2019

TGen-Led Team Prepares to Validate 'TARDIS' Blood-Based Cancer Monitoring Method Published on Aug 09, 2019

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases  In this webinar, Shondra Miller of St. Jude Children's Research Hospital will discuss the pros and cons of several Cas9 variants and orthologues and how these alternative nucleases can be applied to genome editing workflows. Register Now

Recommended for You

New Sample Prep Technique Enables Analysis of DNA from Contaminated Neanderthal Samples Published on Jul 15, 2019  Selection Signals Uncovered In African Rainforest Hunter-Gatherer Exomes Published on Aug 09, 2019

What’s the Correlation Between Mutations Found in FFPE Tumor Tissue and Paired cfDNA Samples? This scientific poster from Beckman Coulter presents a comparison of matched FFPE and plasma samples to determine how many mutations are seen in both tissues. Download it from GenomeWeb’s White Paper Channel.